Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.
Müller-Jensen L, Schulz AR, Mei HE, Mohr R, Ulrich C, Knape P, Frost N, Frischbutter S, Kunkel D, Schinke C, Ginesta Roque L, Maierhof SK, Nickel FT, Heinzerling L, Endres M, Boehmerle W, Huehnchen P, Knauss S. Müller-Jensen L, et al. Among authors: heinzerling l. Neuro Oncol. 2024 Feb 2;26(2):279-294. doi: 10.1093/neuonc/noad198. Neuro Oncol. 2024. PMID: 37823709
[Neurological side effects of checkpoint inhibitors].
Knauss S, Ginesta Roque L, Hühnchen P, Heinzerling L, Böhmerle W, Endres M. Knauss S, et al. Among authors: heinzerling l. Nervenarzt. 2019 Feb;90(2):138-147. doi: 10.1007/s00115-018-0571-8. Nervenarzt. 2019. PMID: 30073487 German.
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank CU, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel JC, Ugurel S, Zimmer L, Banks P, Spain L, Soon JA, Enokida T, Tahara M, Kähler KC, Seggewiss-Bernhardt R, Harvey C, Long GV, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French LE, Knauss S, Heinzerling LM. Müller-Jensen L, et al. Among authors: heinzerling lm. Eur J Cancer. 2022 Nov;175:224-235. doi: 10.1016/j.ejca.2022.08.009. Epub 2022 Sep 22. Eur J Cancer. 2022. PMID: 36155116 Free article.
Checkpoint-inhibitor induced Polyserositis with Edema.
Zierold S, Akcetin LS, Gresser E, Maier AM, König A, Kramer R, Theurich S, Tomsitz D, Erdmann M, French LE, Rudelius M, Heinzerling L. Zierold S, et al. Among authors: heinzerling l. Cancer Immunol Immunother. 2022 Dec;71(12):3087-3092. doi: 10.1007/s00262-022-03211-7. Epub 2022 May 16. Cancer Immunol Immunother. 2022. PMID: 35576074 Free PMC article.
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, Compter A, Harrer T, Mijočević H, Schubert S, Hundsberger T, Menzies AM, Scolyer RA, Long GV, French LE, Blank CU, Heinzerling LM. Schmitt C, et al. Among authors: heinzerling lm. Cancer Immunol Immunother. 2023 Nov;72(11):3475-3489. doi: 10.1007/s00262-023-03498-0. Epub 2023 Aug 22. Cancer Immunol Immunother. 2023. PMID: 37606856 Free PMC article.
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.
Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, Ertl C, Tomsitz D, Tietze JK, Gutzmer R, Dabrowski E, Zimmer L, Gesierich A, Zierold S, French LE, Eigentler T, Amaral T, Heinzerling L. Ruf T, et al. Among authors: heinzerling l. Eur J Cancer. 2024 May;203:114028. doi: 10.1016/j.ejca.2024.114028. Epub 2024 Mar 27. Eur J Cancer. 2024. PMID: 38652976 Free article.
Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis.
Lankes K, Hundorfean G, Harrer T, Pommer AJ, Agaimy A, Angelovska I, Tajmir-Riahi A, Göhl J, Schuler G, Neurath MF, Hohenberger W, Heinzerling L. Lankes K, et al. Among authors: heinzerling l. Oncoimmunology. 2016 Feb 18;5(6):e1128611. doi: 10.1080/2162402X.2015.1128611. eCollection 2016 Jun. Oncoimmunology. 2016. PMID: 27471608 Free PMC article.
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.
Brüggemann C, Kirchberger MC, Goldinger SM, Weide B, Konrad A, Erdmann M, Schadendorf D, Croner RS, Krähenbühl L, Kähler KC, Hafner C, Leisgang W, Kiesewetter F, Dummer R, Schuler G, Stürzl M, Heinzerling L. Brüggemann C, et al. Among authors: heinzerling l. J Cancer Res Clin Oncol. 2017 Oct;143(10):1977-1984. doi: 10.1007/s00432-017-2450-2. Epub 2017 Jun 14. J Cancer Res Clin Oncol. 2017. PMID: 28616701
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.
Zlotoff DA, Hassan MZO, Zafar A, Alvi RM, Awadalla M, Mahmood SS, Zhang L, Chen CL, Ederhy S, Barac A, Banerji D, Jones-O'Connor M, Murphy SP, Armanious M, Forrestal BJ, Kirchberger MC, Coelho-Filho OR, Rizvi MA, Sahni G, Mandawat A, Tocchetti CG, Hartmann S, Gilman HK, Zatarain-Nicolás E, Mahmoudi M, Gupta D, Sullivan R, Ganatra S, Yang EH, Heinzerling LM, Thuny F, Zubiri L, Reynolds KL, Cohen JV, Lyon AR, Groarke J, Thavendiranathan P, Nohria A, Fradley MG, Neilan TG. Zlotoff DA, et al. Among authors: heinzerling lm. J Immunother Cancer. 2021 Mar;9(3):e002007. doi: 10.1136/jitc-2020-002007. J Immunother Cancer. 2021. PMID: 33653803 Free PMC article.
227 results